SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-003750
Filing Date
2024-01-16
Accepted
2024-01-16 16:17:10
Documents
13
Period of Report
2024-01-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191680-8k_adialpharma.htm   iXBRL 8-K 36465
  Complete submission text file 0001213900-24-003750.txt   254236

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adil-20240111.xsd EX-101.SCH 3497
3 XBRL DEFINITION FILE adil-20240111_def.xml EX-101.DEF 26516
4 XBRL LABEL FILE adil-20240111_lab.xml EX-101.LAB 36424
5 XBRL PRESENTATION FILE adil-20240111_pre.xml EX-101.PRE 25140
7 EXTRACTED XBRL INSTANCE DOCUMENT ea191680-8k_adialpharma_htm.xml XML 4991
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 24535356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)